BACKGROUND: Restless legs syndrome (RLS) is a common sleep disorder in which urges to move the legs are felt during rest, are felt at night, and are improved by leg movement. RLS has been implicated in the development of cardiovascular disease. Periodic leg movements (PLMs) may be a mediator of this relationship. We evaluated systemic inflammation and PLMs in RLS patients to further assess cardiovascular risk. METHODS: 137 RLS patients had PLM measurements taken while unmedicated for RLS. Banked plasma was assayed for high sensitivity C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-alpha). RESULTS: Mean (SD) PLM index was 19.3 (22.0). PLMs were unrelated to TNF-a and IL-6, but were modestly correlated with logCRP (r(129)=0.19, p=0.03). Those patients with at least 45PLMs/h had an odds ratio of 3.56 (95% CI 1.26-10.03, p=0.02, df=1) for having elevated CRP compared to those with fewer than 45PLMs/h. After adjustment for age, race, gender, diabetes, hypertension, hyperlipidemia, inflammatory disorders, CRP-lowering medications, and body mass index, the OR for those with ≥ 45PLMs/h was 8.60 (95% CI 1.23 to 60.17, p=0.03, df=10). CONCLUSIONS: PLMs are associated with increased inflammation, such that those RLS patients with at least 45PLMs/h had more than triple the odds of elevated CRP than those with fewer PLMs. Further investigation into PLMs and inflammation is warranted.
BACKGROUND:Restless legs syndrome (RLS) is a common sleep disorder in which urges to move the legs are felt during rest, are felt at night, and are improved by leg movement. RLS has been implicated in the development of cardiovascular disease. Periodic leg movements (PLMs) may be a mediator of this relationship. We evaluated systemic inflammation and PLMs in RLSpatients to further assess cardiovascular risk. METHODS: 137 RLSpatients had PLM measurements taken while unmedicated for RLS. Banked plasma was assayed for high sensitivity C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-alpha). RESULTS: Mean (SD) PLM index was 19.3 (22.0). PLMs were unrelated to TNF-a and IL-6, but were modestly correlated with logCRP (r(129)=0.19, p=0.03). Those patients with at least 45PLMs/h had an odds ratio of 3.56 (95% CI 1.26-10.03, p=0.02, df=1) for having elevated CRP compared to those with fewer than 45PLMs/h. After adjustment for age, race, gender, diabetes, hypertension, hyperlipidemia, inflammatory disorders, CRP-lowering medications, and body mass index, the OR for those with ≥ 45PLMs/h was 8.60 (95% CI 1.23 to 60.17, p=0.03, df=10). CONCLUSIONS: PLMs are associated with increased inflammation, such that those RLSpatients with at least 45PLMs/h had more than triple the odds of elevated CRP than those with fewer PLMs. Further investigation into PLMs and inflammation is warranted.
Authors: Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor Journal: Circulation Date: 2003-01-28 Impact factor: 29.690
Authors: Abu S M Shamsuzzaman; Mikolaj Winnicki; Paola Lanfranchi; Robert Wolk; Tomas Kara; Valentina Accurso; Virend K Somers Journal: Circulation Date: 2002-05-28 Impact factor: 29.690
Authors: A N Vgontzas; D A Papanicolaou; E O Bixler; A Kales; K Tyson; G P Chrousos Journal: J Clin Endocrinol Metab Date: 1997-05 Impact factor: 5.958
Authors: Gloria Y F Ho; Xiao-Nan Xue; Robert D Burk; Robert C Kaplan; Elaine Cornell; Mary Cushman Journal: Cytokine Date: 2005-04-07 Impact factor: 3.861
Authors: Emilia Sforza; Vincent Pichot; Jean Claude Barthelemy; José Haba-Rubio; Frederic Roche Journal: Clin Neurophysiol Date: 2005-05 Impact factor: 3.708
Authors: Diego Garcia-Borreguero; Oscar Larrosa; Yolanda de la Llave; Juan José Granizo; Richard Allen Journal: Sleep Med Date: 2004-11 Impact factor: 3.492
Authors: Klaus Berger; Arnold von Eckardstein; Claudia Trenkwalder; Andreas Rothdach; Ralf Junker; Stephan Karl Weiland Journal: J Neurol Date: 2002-09 Impact factor: 4.849
Authors: John Danesh; Jeremy G Wheeler; Gideon M Hirschfield; Shinichi Eda; Gudny Eiriksdottir; Ann Rumley; Gordon D O Lowe; Mark B Pepys; Vilmundur Gudnason Journal: N Engl J Med Date: 2004-04-01 Impact factor: 91.245
Authors: Anna Svatikova; Robert Wolk; Abu S Shamsuzzaman; Tomas Kara; Eric J Olson; Virend K Somers Journal: Circulation Date: 2003-09-02 Impact factor: 29.690
Authors: Michael D Wirth; Jason R Jaggers; Wesley D Dudgeon; James R Hébert; Shawn D Youngstedt; Steven N Blair; Gregory A Hand Journal: AIDS Behav Date: 2015-06
Authors: Mehrnaz Shokrollahi; Sridhar Krishnan; Dustin D Dopsa; Ryan T Muir; Sandra E Black; Richard H Swartz; Brian J Murray; Mark I Boulos Journal: Med Biol Eng Comput Date: 2016-02-13 Impact factor: 2.602
Authors: Mark I Boulos; Brian J Murray; Ryan T Muir; Fuqiang Gao; Gregory M Szilagyi; Menal Huroy; Alexander Kiss; Arthur S Walters; Sandra E Black; Andrew S Lim; Richard H Swartz Journal: Sleep Date: 2017-03-01 Impact factor: 5.849